We consider treatment-effect estimation under a parallel trends assumption, in heterogeneous adoption designs where no unit is treated at period one, and units receive a weakly positive dose at period two. First, we develop a test of the assumption that the treatment effect is mean independent of the treatment, under which the commonly-used two-way-fixed-effects estimator is consistent. When this test is rejected, we propose alternative, robust estimators. If there are stayers with a period-two treatment equal to 0, the robust estimator is a difference-in-differences (DID) estimator using stayers as the control group. If there are quasi-stayers with a period-two treatment arbitrarily close to zero, the robust estimator is a DID using units with a period-two treatment below a bandwidth as controls. Finally, without stayers or quasi-stayers, we propose non-parametric bounds, and an estimator relying on a parametric specification of treatment-effect heterogeneity. We use our results to revisit Pierce and Schott (2016) and Enikolopov et al. (2011).
No takes yet. Share an insight, caveat, or question.
Chaisemartin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: